Tech Company Financing Transactions

MiRagen Therapeutics Funding Round

MiRagen Therapeutics closed a $6 million financing round on 1/4/2012. Investors included private investors.

Transaction Overview

Announced On
1/4/2012
Transaction Type
Debt
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6200 Lookout Rd. 100
Boulder, CO 80301
USA
Email Address
Overview
Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.
Profile
MiRagen Therapeutics LinkedIn Company Profile
Social Media
MiRagen Therapeutics Company Twitter Account
Company News
MiRagen Therapeutics News
Facebook
MiRagen Therapeutics on Facebook
YouTube
MiRagen Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
William Marshall
  William Marshall LinkedIn Profile  William Marshall Twitter Account  William Marshall News  William Marshall on Facebook
Chief Financial Officer
Jason Leverone
  Jason Leverone LinkedIn Profile  Jason Leverone Twitter Account  Jason Leverone News  Jason Leverone on Facebook
VP - Bus. Development
Christopher Morl
  Christopher Morl LinkedIn Profile  Christopher Morl Twitter Account  Christopher Morl News  Christopher Morl on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/4/2012: Renmatix venture capital transaction
Next: 1/4/2012: Seismic Games venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to document all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary